Education
About Us
Working with TipRanks
Follow Us
Cibus, Inc. (CBUS)
NASDAQ:CBUS
CBUS Stock Chart & Stats
$1.26
-$0.23(-7.99%)
At close: 4:00 PM EST
$1.26
-$0.23(-7.99%)
Day’s Range― - ―
52-Week Range$1.09 - $3.40
Previous CloseN/A
Volume64.89K
Average Volume (3M)154.04K
Market Cap
$95.54M
Enterprise Value$305.48M
Total Cash (Recent Filing)$23.89M
Total Debt (Recent Filing)$33.95M
Price to Earnings (P/E)―
Beta3.04
Next Earnings
Mar 19, 2026EPS Estimate
-0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding52,707,626
10 Day Avg. Volume164,630
30 Day Avg. Volume154,044
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.70
Price to Sales (P/S)15.15
P/FCF Ratio-1.10
Enterprise Value/Market Cap3.20
Enterprise Value/Revenue80.52
Enterprise Value/Gross Profit127.28
Enterprise Value/Ebitda-3.57
Forecast
1Y Price Target
$20.00Price Target Upside1487.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-2.39
Revenue Forecast (FY)$4.17M
Bulls Say, Bears Say
Bulls Say
Cost EfficiencyCibus' bottom-line improved sequentially for a second consecutive quarter, reflecting the company’s standardized RTDS process and cost cutting initiatives announced in January.
Product CommercializationInitial commercialization of the company’s fermentation-based biofragrance products is now underway with revenues in low-single-digit millions expected during the fourth quarter.
Regulatory AdvancementsThe EU agreement creates a pathway for more rapid development of resilient plant varieties in response to climate change-related challenges.
Bears Say
Capital RequirementsIt is apparent that the company will need to raise more capital in 2026, and management reiterated that they are seeking major seed company partners for development partnerships to conserve cash.
Cibus News
CBUS FAQ
What was Cibus, Inc.’s price range in the past 12 months?
Cibus, Inc. lowest stock price was $1.09 and its highest was $3.40 in the past 12 months.
What is Cibus, Inc.’s market cap?
Cibus, Inc.’s market cap is $95.54M.
When is Cibus, Inc.’s upcoming earnings report date?
Cibus, Inc.’s upcoming earnings report date is Mar 19, 2026 which is in 85 days.
How were Cibus, Inc.’s earnings last quarter?
Cibus, Inc. released its earnings results on Nov 13, 2025. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of -$0.438 by -$0.002.
Is Cibus, Inc. overvalued?
According to Wall Street analysts Cibus, Inc.’s price is currently Undervalued.
Does Cibus, Inc. pay dividends?
Cibus, Inc. does not currently pay dividends.
What is Cibus, Inc.’s EPS estimate?
Cibus, Inc.’s EPS estimate is -0.34.
How many shares outstanding does Cibus, Inc. have?
Cibus, Inc. has 52,707,626 shares outstanding.
What happened to Cibus, Inc.’s price movement after its last earnings report?
Cibus, Inc. reported an EPS of -$0.44 in its last earnings report, missing expectations of -$0.438. Following the earnings report the stock price went down -2.4%.
Which hedge fund is a major shareholder of Cibus, Inc.?
Currently, no hedge funds are holding shares in CBUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cibus Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.00 (1487.30% Upside)
$20.00 (1487.30% Upside)
Hedge Fund Trend
Decreased
By 22.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.5%
Last 30 Days ▼ 9.2%
Last 30 Days ▼ 9.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.92%
12-Months-Change
Fundamentals
Return on Equity
-149.99%
Trailing 12-Months
Asset Growth
-10.23%
Trailing 12-Months
Company Description
Cibus, Inc.
Cibus (CBUS) is a biotechnology company focused on developing innovative solutions for crop enhancement and agricultural productivity. The company operates primarily in the agricultural biotechnology sector, specializing in the creation of gene-edited crops that are designed to improve yield, disease resistance, and environmental sustainability. Cibus aims to provide farmers with advanced tools to optimize their farming practices and increase food production while addressing global challenges such as climate change and food security.
CBUS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in commercialization, particularly in rice herbicide tolerance traits and biofragrance products, alongside notable regulatory advances. However, challenges include a revenue decline and cash runway concerns, with some regulatory delays in the EU. Overall, the call reflects a cautiously optimistic outlook.View all CBUS earnings summariesCBUS Stock 12 Month Forecast
Average Price Target
$20.00
▲(1487.30% Upside)
Technical Analysis
CervoMed
―
X4 Pharmaceuticals
―
ABVC BioPharma
―
Repare Therapeutics
―
OKYO Pharma Limited Sponsored ADR
―
Ownership Overview
32.55% Insiders
9.28% Mutual Funds
3.32% Other Institutional Investors
52.79% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---